Septic shock and multiple organ failure are among the most frequent causes of death after trauma and ongoing uncontrolled infection. In the future, an increasing number of patients with severe infection should benefit from several new adjuvant therapies which make use of biological response modifiers. However, the complexity of these new therapies demands an exhaustive knowledge of their mode of action, biological repercussions and pharmaceutical design in order to assess their clinical potential.
This book makes a valuable contribution to the literature in that it provides a comprehensive and methodical review of current progress in anti-cytokine, anti-endotoxin, anti-neutrophil, and anti-arachidonic therapies. It includes an overview of the basic cellular and molecular mechanisms involved as well as an update of current experience with human clinical trials. Featuring contributions from biologists and pharmacologists, the carefully selected papers are authored by international experts from institutions which are renowned for both their outstanding academic research and vigorous clinical activity. Surgeons, critical care providers, and clinicians with an interest in infectious diseases will find this rewarding reading.
"synopsis" may belong to another edition of this title.
Seller: Zubal-Books, Since 1961, Cleveland, OH, U.S.A.
Condition: Good. *Price HAS BEEN REDUCED by 10% until Monday, June 22 (weekend SALE item)* 188 pp., Hardcover, ex library, else text clean and binding tight. - If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country. Seller Inventory # ZB897144